Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TearCare vs Restasis in dry eye disease
NCT04795752Completed
- Sponsor
- Sight Sciences
- Start
- Apr 2021
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (3 arms), sponsored by Sight Sciences. Primary endpoints: Tear Break-Up Time at 6 months and Ocular Surface Disease Index at 6 months. Started Apr 2021; status: completed.
Beyond the preview
Go deeper on NCT04795752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04795752.